BioCardia (BCDA) Cash from Operations (2010 - 2026)

BioCardia (BCDA) has reported Cash from Operations for 16 consecutive years, with -$1.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash from Operations fell 5.22% year-over-year to -$1.7 million in Q2 2026; TTM through Jun 2026 was -$7.6 million, a 9.0% increase from a year earlier, with the FY2025 full-year figure at -$7.4 million, up 5.71% from the prior year.
• Cash from Operations was -$1.7 million for Q2 2026 at BioCardia, down from -$1.7 million in the prior quarter.
• Over five years, Cash from Operations peaked at -$1.3 million in Q2 2024 and troughed at -$3.2 million in Q2 2023.
• A 5-year average of -$2.2 million and a median of -$2.2 million in 2022 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations slumped 54.7% in 2022 and surged 58.36% in 2024, its largest moves.
• Over 5 years, Cash from Operations stood at -$3.0 million in 2022, then jumped by 38.24% to -$1.9 million in 2023, then sank by 31.44% to -$2.4 million in 2024, then dropped by 2.63% to -$2.5 million in 2025, then jumped by 30.52% to -$1.7 million in 2026.
• The last three Cash from Operations figures came in at -$1.7 million (Q2 2026), -$1.7 million (Q1 2026), and -$2.5 million (Q4 2025), per Business Quant data.